Trial
NCT02872649
Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Daniel Zimpfer, MD
Collaborators
—
Condition
Thrombosis
Intervention
Dabigatran
Why stopped
safety reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-19